RESEARCH

Funded Research Projects

Funded Research Projects

Funded Research Projects

Since the creation of the Quebec Research Fund on Parkinson in 2012, Parkinson Québec has contributed to the financing of a number of research projects.

Projects financed in association with the National Research Program of Parkinson Society Canada

Ongoing

Dr. Frédéric Calon
Université Laval
Can exercice and omega-3 fatty acids synergize to restore dopamine neurons in Parkinson’s disease?
2014-2016 ($45,000/1 year)

Dr. Francesca Cicchetti
Université Laval
Microvesicles : biomarkers and vehicles for the propagation of alpha synuclein
2014-2016 ($45,000/1 year)

Dr. Julien Doyon
Institut de gériatrie de Montréal
Effects of aerobic exercise training with or without preferred rhythms on learning new motor skills in patients with Parkinson’s disease
2014-2016 ($44,725/1 year)

Dr. Ronald Postuma
McGill University
Association of cognitive impairment and orthostatic hypotension in patients suffering from Parkinson’s disease
2014-2016 ($40,620/1 year)

Mr. Alexandru Hanganu
Institut Universitaire de Gériatrie de Montréal
Evolution of mild cognitive impairment in patients with Parkinson’s disease
2014-2016 ($80,000, of which the QRFP’s contribution: $30,000/2 years)

Mr. Omid Tavassoly
McGill University
Molecular Mechanism of Alpha-Synuclein Propagation in Parkinson’s disease
2014-2016 ($80,000, of which the QRFP’s contribution: $30,000/2 years)

Mr. Nadhir Litim
Université Laval
Effects of Gonadial Drugs as Neuroprotectors in Animal Models of Parkinson’s Disease
2014-2017 (60,000, of which the QRFP’s contribution: $30,000/3 years)

Mrs. Jessica Trung
McGill University
Cognitive Impairment and Parkinson’s
2014-2017 (60,000, of which the QRFP’s contribution: $30,000/3 years)

Dr. Siegfried Hekimi
McGill University
A ground-breaking screen for drugs that target mitochondrial dysfunction in Parkinson’s disease
2015-2016 ($45,000/1 year)

Dr. Jacques Montplaisir
Université de Montréal
Cholinergic PET imaging as a prodromal marker of PD in REM sleep behaviour disorder
2015-2016 ($44,850/1 year)

Pr. Louis-Eric Trudeau, PhD
Université de Montréal
Dopamine neuron axonal arborization size as a target to influence vulnerability and produce better mouse models of Parkinson’s disease
2015-2016 ($44,240/1 year)

M. Charles Ducrot
Université de Montréal
Survival of Dopamine Neurons in Parkinson’s Disease: The Role of Synaptic Contacts
2015-2017 ($30,000, of which the QRFP’s contribution: $15,000/2 years)

M. Stefano Cataldi
University of British-Columbia
Quebec Research Fund on Parkinson
2016-2018 (30 000$, of wich the QRFP’s contribution: 15 000$/2 years)

Previous

Pr. Alex MacKay
University of British Columbia
Assessment of “normal appearing” white matter in Parkinson’s disease and its association with cognitive dysfunction
2014-2015 ($45,000/1 year)

Pr. Pascale Legault
Université de Montréal
Bio-genesis of microRNA’s associated with Parkinson’s disease
2013-2015 ($45,000/1 year)

Mr. Martin Duennwald
University of Western Ontario
Identification of parkin substrates in early-onset Parkinson’s disease
2013-2015 ($45,000/1 year)

Pr. Brian Staveley
Memorial University
The Pink1-parkin-Paris-Pgc-1a pathway in Drosophila models of Parkinson disease
2012-2014 ($45,000/1 year)

Pr. Jeremy Lee, PhD
University of Saskatchewan
Understanding the misfolding of alpha-synuclein
2012-2014 ($44,100/1year)

Pr. Louis-Éric Trudeau, PhD
Université de Montréal
Evaluating axonal arbor size as a vulnerability factor in Parkinson’s disease
2012-2014 ($45,000/1 year)

Pr. David Stellwagen, PhD
McGill University
TNFalpha mediated synaptic plasticity in Parkinson’s disease and levodopa-induced dyskinesia
2012-2014 ($90,000/2 years)

Dr. Joanne Lemieux, PhD
University of Alberta
In vitro functional and structural study of PINK1 cleavage in Parkinson’s disease
2012-2014 ($90,000/2 years)

Projects financed in association with the Fonds de recherche québécois - Santé

Ongoing

Mr. Dave Gagnon
Université Laval
Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia
2014-2017 ($60,000, of which the QRFP’s contribution: $30,000/3 years)

Mrs. Marjan Seirafi
McGill University
Structural studies of the activated form of the parkin protein
2014-2017 ($60,000, of which the QRFP’s contribution: $30,000/3 years)

Dr. Ronald Postuma
McGill University
1-REM sleep behavior disorder on Prodromal Parkinson’s Disease
2- Caffeine for Parkinson’s Disease
2014-2018 ($126,557, of which the QRFP’s contribution: $25,000/4 years)

Mr. Clifford Cassidy
New York State Psychiatric Institute
Neuromelanine-sensible MRI : une méthode nouvelle et non-invasive pour imager les neurones dopamines fournissant un biomarqueur possible de la maladie de Parkinson
2015-2016 ($45,000, of which the QRFP’s contribution: $15,000/1 year)

Mrs. Andrée-Anne Poirier
Centre de recherche du CHU de Québec
Study of the neuroprotective and anti-inflammatory effects of gonadal hormone modulator treatments on the enteric nervous system in parkinson’s disease
2015-2017 ($30,000, of which the QRFP’s contribution: $10,000/2 years)

Previous

Mrs. Hélène Doucet-Beaupré
Université Laval
The role of developmental transcription factors in adult midbrain dopaminergic neurons
2014-2015 ($30,000, of which the QRFP’s contribution: $15,000/1 year)

Visitez notre >> Centre info Parkinson

Simple Share Buttons